RNAi Therapeutics: Challenges in Drug Development and DeliveryCHI Insight Pharma ReportsOctober 1, 2005 120 Pages - SKU: CHI1197143 |
|
Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition
5/11/2012 | published by: Kalorama Information
The drug discovery process is long, arduous and costly, which has driven outsourcing in this field. The first phase is discovery of a lead compound, a molecule that affects biological function by binding to a
|
more...
|
$3,995.00
|
|
Retinal Vein Occlusion Therapeutics - Pipeline Assessment and Market Forecasts to 2019
5/21/2012 | published by: GlobalData
Retinal Vein Occlusion Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Summary GlobalData, the industry analysis specialist, has released its new report, “Retinal Vein Occlusion Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report
|
more...
|
$3,995.00
|
|
Hemorrhoids Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Hemorrhoids Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Hemorrhoids Global Clinical Trials Review, H1, 2012 provides data on the Hemorrhoids clinical trial scenario. This report provides elemental information and data relating to the
|
more...
|
$1,000.00
|
|
Hepatic Encephalopathy Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Hepatic Encephalopathy Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Hepatic Encephalopathy Global Clinical Trials Review, H1, 2012 provides data on the Hepatic Encephalopathy clinical trial scenario. This report provides elemental information and data
|
more...
|
$1,000.00
|
|
Hepatic Injury Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Hepatic Injury Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Hepatic Injury Global Clinical Trials Review, H1, 2012 provides data on the Hepatic Injury clinical trial scenario. This report provides elemental information and data
|
more...
|
$1,000.00
|
|
Presbyopia Global Clinical Trials Review, H1, 2012
4/12/2012 | published by: GlobalData
Presbyopia Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Presbyopia Global Clinical Trials Review, H1, 2012 provides data on the Presbyopia clinical trial scenario. This report provides elemental information and data relating to the
|
more...
|
$1,000.00
|
|
Clinical Trials Market in India 2012
4/13/2012 | published by: Netscribes (India) Pvt. Ltd.
The Indian clinical trials market is growing at an excellent rate and currently witnessing a large number of global pharmaceutical companies outsourcing trials to contract research organizations (CROs) in India. This is largely due to
|
more...
|
$795.00
|
|
Metastatic Hepatocellular Carcinoma (HCC) – Pipeline Review, H1 2012
4/19/2012 | published by: Global Markets Direct
Metastatic Hepatocellular Carcinoma (HCC) – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H1 2012', provides an overview of the Metastatic Hepatocellular Carcinoma (HCC) therapeutic pipeline. This report provides information
|
more...
|
$500.00
|
|
Hepatic Insufficiency Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Hepatic Insufficiency Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Hepatic Insufficiency Global Clinical Trials Review, H1, 2012 provides data on the Hepatic Insufficiency clinical trial scenario. This report provides elemental information and data
|
more...
|
$1,000.00
|
|
2012 European Nucleic Acid Testing Market: France, Germany, Italy, Spain, UK Emerging Opportunities and Business Expansion Strategies
4/24/2012 | published by: Venture Planning Group
This comprehensive five-country report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years. The report explores business
|
more...
|
$18,500.00
|
Related Markets
Drug Discovery Reports
- Biosensors - A Global Market Overview
- Nucleic Acid Therapies in Oncology Drug Pipeline Update 2012
- Stem Cells: Worldwide Markets for Transplantation and Cord Blood Banking (Projections for Stem Cell Use in Cancer, Alzheimer’s, Diabetes, Arthritis and Other Diseases)
- Synthetic Biology: Emerging Global Markets
- Biomarkers in Drug Discovery - Earlier Usage of Biomarkers in Optimization Stage to Reduce Drug Attrition Rate Significantly
